BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pandith AA, Khan NP, Rashid N, Azad N, Zaroo I, Hafiz A, Siddiqi MA. Impact of codon 72 Arg > Pro single nucleotide polymorphism in TP53 gene in the risk of kangri cancer: a case control study in Kashmir. Tumour Biol 2012;33:927-33. [PMID: 22249977 DOI: 10.1007/s13277-012-0318-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Mancini F, Giorgini L, Teveroni E, Pontecorvi A, Moretti F. Role of Sex in the Therapeutic Targeting of p53 Circuitry. Front Oncol 2021;11:698946. [PMID: 34307167 DOI: 10.3389/fonc.2021.698946] [Reference Citation Analysis]
2 Yang T, Wen Y, Li J, Yang J, Tan T, Pan J, Hu C, Zhang J, Xin Y, Li S, Xia H, He J, Zou Y. Association of the TP53 rs1042522 C>G polymorphism and hepatoblastoma risk in Chinese children. J Cancer 2019;10:3444-9. [PMID: 31293648 DOI: 10.7150/jca.33063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
3 Yan Y, Wu R, Li S, He J. Meta-analysis of association between the TP53 Arg72Pro polymorphism and risk of endometriosis based on case-control studies. Eur J Obstet Gynecol Reprod Biol 2015;189:1-7. [PMID: 25819169 DOI: 10.1016/j.ejogrb.2015.03.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
4 Bhandari PR, Pai VV. Novel medical strategies combating nonmelanoma skin cancer. Indian J Dermatol 2014;59:531-46. [PMID: 25484380 DOI: 10.4103/0019-5154.143503] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
5 Mandal RK, Yadav SS, Panda AK. No evidence of correlation between p53 codon 72 G > C gene polymorphism and cancer risk in Indian population: a meta-analysis. Tumor Biol 2014;35:8607-13. [DOI: 10.1007/s13277-014-2114-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
6 Hu S, Zhao L, Yang J, Hu M. The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 cases. Tumour Biol 2014;35:3647-56. [PMID: 24326769 DOI: 10.1007/s13277-013-1483-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
7 Ye J, Li XF, Wang YD, Yuan Y. Arg72Pro polymorphism of TP53 gene and the risk of skin cancer: a meta-analysis. PLoS One 2013;8:e79983. [PMID: 24260330 DOI: 10.1371/journal.pone.0079983] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
8 Hu S, Zhao L, Yang J, Hu M. The association between polymorphism of P53 codon 72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3704 cases. Meta Gene 2013;1:126-37. [PMID: 25606382 DOI: 10.1016/j.mgene.2013.09.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Lv L, Wang P, Zhou X, Sun B. Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk. Tumour Biol 2013;34:1451-9. [PMID: 23564481 DOI: 10.1007/s13277-013-0649-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]